EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $631 | +63000.0% | 40 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | -99.9% | 40 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | -50.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $2,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |